| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Pulmonary Medicine, Erasmus Medical Center, Rotterdam, The Netherlands; and
Institut National de la Santé et de la Recherche Médicale, Unité 547, Institut Pasteur de Lille, Lille, France
PGD2 is the major mediator released by mast cells during allergic responses, and it acts through two different receptors, the D prostanoid receptor 1 (DP1) and DP2, also known as CRTH2. Recently, it has been shown that PGD2 inhibits the migration of epidermal Langerhans cells to the skin draining lymph nodes (LNs) and affects the subsequent cutaneous inflammatory reaction. However, the role of PGD2 in the pulmonary immune response remains unclear. Here, we show that the intratracheal instillation of FITC-OVA together with PGD2 inhibits the migration of FITC+ lung DC to draining LNs. This process is mimicked by the DP1 agonist BW245C, but not by the DP2 agonist DK-PGD2. The ligation of DP1 inhibits the migration of FITC-OVA+ DCs only temporarily, but still inhibits the proliferation of adoptively transferred, OVA-specific, CFSE-labeled, naive T cells in draining LNs. These T cells produced lower amounts of the T cell cytokines IL-4, IL-10, and IFN-
compared with T cells from mice that received FITC-OVA alone. Taken together, our data suggest that the activation of DP receptor by PGD2 may represent a pathway to control airway DC migration and to limit the activation of T cells in the LNs under steady state conditions, possibly contributing to homeostasis in the lung.
This article has been cited by other articles:
|
|
 |
|
  J. McGill, J. W. Heusel, and K. L. Legge Innate immune control and regulation of influenza virus infections J. Leukoc. Biol., October 1, 2009; 86(4): 803 - 812. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Boehme, K. Franz-Bacon, E. P. Chen, T. W. Ly, Y. Kawakami, and K. B. Bacon Murine bone marrow-derived mast cells express chemoattractant receptor-homologous molecule expressed on T-helper class 2 cells (CRTh2) Int. Immunol., June 1, 2009; 21(6): 621 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tajima, T. Murata, K. Aritake, Y. Urade, H. Hirai, M. Nakamura, H. Ozaki, and M. Hori Lipopolysaccharide Induces Macrophage Migration via Prostaglandin D2 and Prostaglandin E2 J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 493 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Miyahara, H. Ohnishi, H. Matsuda, S. Miyahara, K. Takeda, T. Koya, S. Matsubara, M. Okamoto, A. Dakhama, B. Haribabu, et al. Leukotriene B4 Receptor 1 Expression on Dendritic Cells Is Required for the Development of Th2 Responses and Allergen-Induced Airway Hyperresponsiveness J. Immunol., July 15, 2008; 181(2): 1170 - 1178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Yoon, S.-B. Jeon, I.-H. Kim, and E. J. Park Regulation of TLR2 Expression by Prostaglandins in Brain Glia J. Immunol., June 15, 2008; 180(12): 8400 - 8409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Torres, C. Paget, J. Fontaine, T. Mallevaey, T. Matsuoka, T. Maruyama, S. Narumiya, M. Capron, P. Gosset, C. Faveeuw, et al. Prostaglandin D2 Inhibits the Production of IFN-{gamma} by Invariant NK T Cells: Consequences in the Control of B16 Melanoma J. Immunol., January 15, 2008; 180(2): 783 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rajakariar, M. Hilliard, T. Lawrence, S. Trivedi, P. Colville-Nash, G. Bellingan, D. Fitzgerald, M. M. Yaqoob, and D. W. Gilroy From the Cover: Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxy{Delta}12-14 PGJ2 PNAS, December 26, 2007; 104(52): 20979 - 20984. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Culver and S. M. Laster Adenovirus Type 5 Exerts Multiple Effects on the Expression and Activity of Cytosolic Phospholipase A2, Cyclooxygenase-2, and Prostaglandin Synthesis J. Immunol., September 15, 2007; 179(6): 4170 - 4179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Chen, B. Perussia, and K. S. Campbell Prostaglandin D2 Suppresses Human NK Cell Function via Signaling through D Prostanoid Receptor J. Immunol., September 1, 2007; 179(5): 2766 - 2773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hammad, M. Kool, T. Soullie, S. Narumiya, F. Trottein, H. C. Hoogsteden, and B. N. Lambrecht Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells J. Exp. Med., February 19, 2007; 204(2): 357 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sandig, J. E. Pease, and I. Sabroe Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte function J. Leukoc. Biol., February 1, 2007; 81(2): 372 - 382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Zhang, Z. Dong, and T. Yang Prostaglandin D2 inhibits TGF-beta1-induced epithelial-to-mesenchymal transition in MDCK cells Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1332 - F1342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Yang, Z. Cai, Y. Zhang, W. H. Yutzy IV, K. F. Roby, and R. B.S. Roden CD80 in Immune Suppression by Mouse Ovarian Carcinoma-Associated Gr-1+CD11b+ Myeloid Cells. Cancer Res., July 1, 2006; 66(13): 6807 - 6815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Y. Park and J. W. Christman Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L797 - L805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Suto, S. Nakae, M. Kakurai, J. D. Sedgwick, M. Tsai, and S. J. Galli Mast Cell-Associated TNF Promotes Dendritic Cell Migration J. Immunol., April 1, 2006; 176(7): 4102 - 4112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Trivedi, J. Newson, R. Rajakariar, T. S. Jacques, R. Hannon, Y. Kanaoka, N. Eguchi, P. Colville-Nash, and D. W. Gilroy Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity PNAS, March 28, 2006; 103(13): 5179 - 5184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Jakubzick, F. Tacke, J. Llodra, N. van Rooijen, and G. J. Randolph Modulation of Dendritic Cell Trafficking to and from the Airways J. Immunol., March 15, 2006; 176(6): 3578 - 3584. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. Hata, T. P. Lybrand, and R. M. Breyer Identification of Determinants of Ligand Binding Affinity and Selectivity in the Prostaglandin D2 Receptor CRTH2 J. Biol. Chem., September 16, 2005; 280(37): 32442 - 32451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Noguchi, E. Kuroda, and U. Yamashita Strain difference of murine bone marrow-derived mast cell functions J. Leukoc. Biol., September 1, 2005; 78(3): 605 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Vermaelen and R. Pauwels Pulmonary Dendritic Cells Am. J. Respir. Crit. Care Med., September 1, 2005; 172(5): 530 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Almishri, C. Cossette, J. Rokach, J. G. Martin, Q. Hamid, and W. S. Powell Effects of Prostaglandin D2, 15-Deoxy-{Delta}12,14-prostaglandin J2, and Selective DP1 and DP2 Receptor Agonists on Pulmonary Infiltration of Eosinophils in Brown Norway Rats J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 64 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. van Rijt, S. Jung, A. KleinJan, N. Vos, M. Willart, C. Duez, H. C. Hoogsteden, and B. N. Lambrecht In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma J. Exp. Med., March 21, 2005; 201(6): 981 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. E. Baratelli, N. Heuze-Vourc'h, K. Krysan, M. Dohadwala, K. Riedl, S. Sharma, and S. M. Dubinett Prostaglandin E2-Dependent Enhancement of Tissue Inhibitors of Metalloproteinases-1 Production Limits Dendritic Cell Migration through Extracellular Matrix J. Immunol., November 1, 2004; 173(9): 5458 - 5466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. de Heer, H. Hammad, T. Soullie, D. Hijdra, N. Vos, M. A.M. Willart, H. C. Hoogsteden, and B. N. Lambrecht Essential Role of Lung Plasmacytoid Dendritic Cells in Preventing Asthmatic Reactions to Harmless Inhaled Antigen J. Exp. Med., July 6, 2004; 200(1): 89 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Takeshita, T. Yamasaki, K. Nagao, H. Sugimoto, M. Shichijo, F. Gantner, and K. B. Bacon CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation Int. Immunol., July 1, 2004; 16(7): 947 - 959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Angeli, D. Staumont, A.-S. Charbonnier, H. Hammad, P. Gosset, M. Pichavant, B. N. Lambrecht, M. Capron, D. Dombrowicz, and F. Trottein Activation of the D Prostanoid Receptor 1 Regulates Immune and Skin Allergic Responses J. Immunol., March 15, 2004; 172(6): 3822 - 3829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hammad, H. J. de Heer, T. Soullie, V. Angeli, F. Trottein, H. C. Hoogsteden, and B. N. Lambrecht Activation of Peroxisome Proliferator-Activated Receptor-{gamma} in Dendritic Cells Inhibits the Development of Eosinophilic Airway Inflammation in a Mouse Model of Asthma Am. J. Pathol., January 1, 2004; 164(1): 263 - 271. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
